As of January 23, 2025, Denali Therapeutics (DNLI) has a market cap of $3.35 billion USD. According to our data, Denali Therapeutics is ranked No.3309 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $3.35 B |
14.38%
|
Dec 31, 2024 | $2.93 B |
-5.03%
|
Dec 29, 2023 | $3.09 B |
-22.83%
|
Dec 30, 2022 | $4.00 B |
-37.65%
|
Dec 31, 2021 | $6.42 B |
-46.75%
|
Dec 31, 2020 | $12.05 B |
380.83%
|
Dec 31, 2019 | $2.51 B |
-15.68%
|
Dec 31, 2018 | $2.97 B |
32.10%
|
Dec 29, 2017 | $2.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | DNLI Stock Price | * | DNLI Shares Outstanding |
= | $23.31 | * | 0.14 B | |
= | $3.35 B |